ST-segment elevation myocardial infarction (STEMI)

Latest STEMI content in interventional cardiology - research, practice, and education

Treating STEMI brings into play a series of clinical and organisational protocols in constant evolution. Today, patients presenting with STEMI are best treated by early reperfusion strategies of which primary PCI is the preferred method. Keep up-to-date on the role of adjunctive pharmacotherapy, advances in imaging techniques and the use of invasive imaging and functional assessment. Tools, devices and techniques as well as complications, such as the different types of vascular access or bleeding risk can be found here as well…

Filtered By
STEMI

412 results

How should I treat my female patients?

07 Dec 2023 – From GulfPCR-GIM 2023

This 100% all-female session, in every aspect, highlights the fact that female patients have a higher prevalence of SCAD and MINOCA, focuses on the advances in everyday technologies such as intracoronary imaging and intracoronary functional assessment that facilitate the establishment of a definitive diagnosis in many...

How should I treat my female patients?

Uncommon causes of coronary ischaemia: expect the unexpected!

06 Dec 2023 – From GulfPCR-GIM 2023

Broaden your knowledge and learn about unusual causes of coronary ischaemia. Explore a variety of cases, including the discovery of a coronary fistula, how to diagnose coronary subclavian steal syndrome (CSSS), and more!

Challenging STEMI scenarios: part 1

06 Dec 2023 – From GulfPCR-GIM 2023

Explore a selection of case studies focusing on challenging STEMI scenarios, such as an inferior STEMI with a large thrombus burden, management of coronary dissection in a patient with ectatic coronary artery, and an unusual case of an RCA with an anomalous origin. 

Left main stenting: one vs. two stent strategy

06 Dec 2023 – From GulfPCR-GIM 2023

In these selected clinical cases, discover strategies on whether to choose one or two stents in the case of left main disease. Explore the use of effective imaging, IABP, and other mechanical support devices.

When complications storm through the cathlab: part 1

06 Dec 2023 – From GulfPCR-GIM 2023

Challenging scenarios in STEMI patients

06 Dec 2023 – From GulfPCR-GIM 2023

This session tackles complex scenarios encountered in STEMI interventions, ranging from conditions affecting the left main stem (LMS) to managing extensive thrombus burdens, explore strategies when patients have a history of previous stents, address treatment approaches for those with multivessel disease, and deliberate on strategies when...

Challenging scenarios in STEMI patients

Half-dose tenecteplase or primary PCI in older patients with ST-elevation myocardial infarction: The STREAM-2 1-year mortality follow-up results

15 Nov 2023

Aaysha Cader interviews Peter Sinnaeve on the STREAM-2 1-year mortality follow-up results, which were presented at the AHA 2023 Congress in Philadelphia.
Results suggest that a pharmaco-invasive strategy provides an alternative for older STEMI patients unable to undergo primary PCI.

Author

Aaysha Cader
Peter Sinnaeve

Author

Peter Sinnaeve
Half-dose tenecteplase or primary PCI in older patients with ST-elevation myocardial infarction: The STREAM-2 1-year mortality follow-up results

AHA 2023: get the interventional cardiology perspective!

11 Nov 2023

Stay up to date with what is new and hot in interventional cardiology at #AHA23 in Philadelphia.

PCRonline @ AHA 2023

The randomized PICSO-AMI-I trial: pressure-controlled intermittent coronary sinus occlusion in acute myocardial infarction

27 Oct 2023

Aaysha Cader interviews Giovanni Luigi De Maria about the results of the PICSO-AMI-I Trial which he presented during the TCT Congress 2023 in San Francisco.

Author

Aaysha Cader
Giovanni Luigi De Maria

Author

Giovanni Luigi De Maria
Pressure-Controlled Intermittent Coronary Sinus Occlusion (PiCSO) in Acute Myocardial Infarction: The Randomized PICSO-AMI-I Trial

T-PASS: Less than 1-month DAPT followed by ticagrelor monotherapy after DES Implantation for ACS

26 Oct 2023

Ali Nazmi Calik interviews Myeong-Ki Hong about the results of the T-Pass randomised trial which he presented during the #TCT Congress 2023 in San Francisco.

Myeong-Ki Hong

Author

Myeong-Ki Hong

Author

Ali Nazmi Calik
T-PASS: Less than 1-month DAPT followed by ticagrelor monotherapy after DES Implantation for ACS